Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
AUTOR(ES)
Hamel, Nancy
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=194219Documentos Relacionados
- Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations
- Founder Mutations of BRCA1 and BRCA2 in North American Families of Polish Origin That Are Affected with Breast Cancer
- Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene
- Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation
- Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes : A Supplement to HRMCA Mutation Scanning, Allowing the Strong Reduction of Sequencing Burden